Gene · 10219
Papers3,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combination of a MIP3α-antigen fusion therapeutic DNA vaccine with treatments of IFNα and 5-Aza-2'Deoxycytidine enhances activated effector CD8+ T cells expressing CD11c in the B16F10 melanoma model. | Res Sq | 2024 | 37645859 | PubTator, text mining | PubMed |
| Multimodal hierarchical classification of CITE-seq data delineates immune cell states across lineages and tissues. | bioRxiv | 2024 | 37461466 | PubTator, text mining | PubMed |
| The Entangled World of Memory T Cells and Implications in Transplantation. | Transplantation | 2024 | 37271872 | PubTator, text mining | PubMed |
| ENOX2 inhibition enhances infiltration of effector memory T-cell and mediates response to chemotherapy in immune-quiescent nasopharyngeal carcinoma. | J Adv Res | 2024 | 37061217 | PubTator, text mining | PubMed |
| Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis? | Front Public Health | 2023 | 38259741 | PubTator, text mining | PubMed |
| NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens. | Front Immunol | 2023 | 38235131 | PubTator, text mining | PubMed |
| Dissecting molecular mechanisms of immune microenvironment dysfunction in multiple myeloma and precursor conditions. | J Cancer Metastasis Treat | 2023 | 38213954 | PubTator, text mining | PubMed |
| New perspectives on biology, disease progression, and therapy response of head and neck cancer gained from single cell RNA sequencing and spatial transcriptomics. | Oncol Res | 2023 | 38188682 | PubTator, text mining | PubMed |
| Current annotation strategies for T cell phenotyping of single-cell RNA-seq data. | Front Immunol | 2023 | 38187377 | PubTator, text mining | PubMed |
| Single cell RNA-sequencing profiling to improve the translation between human IBD and in vivo models. | Front Immunol | 2023 | 38179052 | PubTator, text mining | PubMed |
| 50-color phenotyping of the human immune system with in-depth assessment of T cells and dendritic cells. | bioRxiv | 2023 | 38168221 | PubTator, text mining | PubMed |
| Targeting the immune microenvironment for ovarian cancer therapy. | Front Immunol | 2023 | 38164130 | PubTator, text mining | PubMed |
| Selective ablation of thymic and peripheral Foxp3+ regulatory T cell development. | Front Immunol | 2023 | 38164128 | PubTator, text mining | PubMed |
| Canonical IRE1 function needed to sustain vigorous natural killer cell proliferation during viral infection. | iScience | 2023 | 38162021 | PubTator, text mining | PubMed |
| The Eradication of Carcinogenic Viruses in Established Solid Cancers. | J Inflamm Res | 2023 | 38145011 | PubTator, text mining | PubMed |
| c-Met+ Cytotoxic T Lymphocytes Exhibit Enhanced Cytotoxicity in Mice and Humans In Vitro Tumor Models. | Biomedicines | 2023 | 38137344 | PubTator, text mining | PubMed |
| Implications of Senescent T Cells for Cancer Immunotherapy. | Cancers (Basel) | 2023 | 38136380 | PubTator, text mining | PubMed |
| Modulation of Epstein-Barr-Virus (EBV)-Associated Cancers by Co-Infections. | Cancers (Basel) | 2023 | 38136285 | PubTator, text mining | PubMed |
| Feasibility and acceptability of undertaking postmortem studies for tuberculosis medical research in a low income country. | Front Immunol | 2023 | 38130719 | PubTator, text mining | PubMed |
| Unique adipose tissue invariant natural killer T cell subpopulations control adipocyte turnover in mice. | Nat Commun | 2023 | 38129377 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10219/papers?page=12